Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders??? Equity (Deficit)

v3.24.1
Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss)
Accumulated Deficit
Balance as of beginning of period (in shares) at Dec. 31, 2021   183,232,494      
Balance as of beginning of period at Dec. 31, 2021 $ 110,415,000 $ 2,000 $ 340,294,000 $ (14,000) $ (229,867,000)
Balance as of end of period at Mar. 31, 2022 49,321,000        
Balance as of beginning of period (in shares) at Dec. 31, 2021   183,232,494      
Balance as of beginning of period at Dec. 31, 2021 $ 110,415,000 $ 2,000 340,294,000 (14,000) (229,867,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 2,981,000 2,980,626      
Issuance of common stock upon exercise of stock options $ 1,256,000   1,256,000    
Stock-based compensation 20,148,000 $ 1,348,248 20,148,000    
Adjustments to Additional Paid in Capital, Warrant Issued (170,000)   (170,000)    
Net income (loss) 7,969,000       7,969,000
Other comprehensive loss (823,000)     (823,000)  
Balance as of end of period (in shares) at Dec. 31, 2022   187,561,368      
Balance as of end of period at Dec. 31, 2022 138,795,000 $ 2,000 361,528,000 (837,000) (221,898,000)
Balance as of beginning of period at Mar. 31, 2022 49,321,000        
Balance as of end of period at Jun. 30, 2022 181,688,000        
Balance as of end of period at Sep. 30, 2022 110,797,000        
Balance as of end of period (in shares) at Dec. 31, 2022   187,561,368      
Balance as of end of period at Dec. 31, 2022 138,795,000 $ 2,000 361,528,000 (837,000) (221,898,000)
Balance as of end of period at Mar. 31, 2023 119,762,000        
Balance as of beginning of period (in shares) at Dec. 31, 2022   187,561,368      
Balance as of beginning of period at Dec. 31, 2022 $ 138,795,000 $ 2,000 361,528,000 (837,000) (221,898,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 2,204,000 2,190,061      
Issuance of common stock upon exercise of stock options $ 561,000   561,000    
Stock-based compensation 24,931,000 $ 5,493,207 24,931,000    
Shares Issued, Shares, Share-Based Payment Arrangement, At-the-Market Offering, Net of Issuance Costs   17,174,059      
Adjustments to Additional Paid in Capital, At-the-Market offering, net of issuance costs 22,805,000   22,805,000    
Shares Issued, Shares, Share-Based Payment Arrangement, Capital Raise, Net of Issuance Costs   36,000,000      
Issuance of common stock in connection with capital raise, net of issuance costs 6,216,000   6,216,000    
Shares Issued, Shares, Share-Based Payment Arrangement, Debt Exinguishment   10,000,000      
Issuance of common stock in connection with debt extinguishment 9,430,000   9,430,000    
Net income (loss) (135,139,000)       (135,139,000)
Other comprehensive loss 741,000     741,000  
Balance as of end of period (in shares) at Dec. 31, 2023   258,418,695      
Balance as of end of period at Dec. 31, 2023 68,340,000 $ 2,000 425,471,000 (96,000) (357,037,000)
Balance as of beginning of period at Mar. 31, 2023 119,762,000        
Balance as of end of period at Jun. 30, 2023 108,417,000        
Balance as of end of period at Sep. 30, 2023 98,709,000        
Balance as of end of period (in shares) at Dec. 31, 2023   258,418,695      
Balance as of end of period at Dec. 31, 2023 $ 68,340,000 $ 2,000 $ 425,471,000 $ (96,000) $ (357,037,000)